Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanoma
Alexander M. Menzies, Serigne Lo, Robyn P.M. Saw, Maria Gonzalez, Sydney Ch’ng, O E Nieweg, Kerwin F. Shannon, P M Ferguson, Jenny Lee, Louise Emmett, R Kapoor, R V Rawson, Jonathan R. Stretch, John F. Thompson, A J Spillane, Helen Rizos, R A Scolyer, Georgina V. Long
Topics & Concepts
TrametinibDabrafenibMedicineOncologyMelanomaInternal medicineStage (stratigraphy)Cancer researchVemurafenibMetastatic melanomaGeneticsMAPK/ERK pathwayKinasePaleontologyBiologyMelanoma and MAPK PathwaysCutaneous Melanoma Detection and ManagementBrain Metastases and Treatment